John N. Staniforth

All filings by John N. Staniforth on record concern Penwest Pharmaceuticals Co. In total, 18 filings cover trades dated from 3 January 2006 to 2 January 2009.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 5 January 2009 came the latest disclosure, a share grant in Penwest Pharmaceuticals Co. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.